Maria Rodanaki1, Maria Lodefalk2,3, Katharina Forssell4, Carl-Göran Arvidsson5, Maria Forssberg4, Jan Åman1. 1. Department of Paediatrics, School of Medical Sciences, Örebro University, Örebro, Sweden. 2. Department of Paediatrics, School of Medical Sciences, Örebro University, Örebro, Sweden, maria.lodefalk@regionorebrolan.se. 3. University Health Care Research Center, Faculty of Medicine and Health, Örebro University, Örebro, Sweden, maria.lodefalk@regionorebrolan.se. 4. Department of Paediatrics, Central Hospital, Karlstad, Sweden. 5. Department of Paediatrics, Västerås Hospital, Västerås, Sweden.
Abstract
BACKGROUND: We found an increase in the incidence rate (IR) of childhood thyrotoxicosis (CT) during the 1990s in central Sweden. The optimal treatment method for CT is a subject that is still debated upon. OBJECTIVES: To investigate whether the increase in IR of CT in Sweden persists and to study the treatment outcome. METHOD: Children <16 years of age diagnosed with CT during 2000-2009 and living in 1 of 5 counties in central Sweden were identified retrospectively using hospital registers. Data on clinical and biochemical characteristics and outcomes of treatment were collected from medical records. The corresponding data from 1990 to 1999 were pooled with the new data. RESULTS: In total, 113 children were diagnosed with CT during 1990-2009 in the study area. The overall IR was 2.2/100,000 person-years (95% CI 1.2-2.5/100,000 person-years). The IR was significantly higher during 2000-2009 than during 1990-1999 (2.8/100,000 [2.2-3.6] vs. 1.6/100,000 person-years [1.2-2.2], p = 0.006). The increase was significant for both sexes. Seventy percent of the patients who completed the planned initial treatment with antithyroid drugs (ATDs) and were not lost to follow-up relapsed within 3 years. Boys tended to relapse earlier than girls (6.0 months after drug withdrawal [95% CI 1.9-10.0] vs. 12.0 months [95% CI 6.8-17.3], p = 0.074). CONCLUSIONS: The IR of CT is increasing in both girls and boys. Relapse rate after withdrawal of ATD treatment is 70%. Boys tend to relapse earlier than girls, and this needs to be further investigated.
BACKGROUND: We found an increase in the incidence rate (IR) of childhood thyrotoxicosis (CT) during the 1990s in central Sweden. The optimal treatment method for CT is a subject that is still debated upon. OBJECTIVES: To investigate whether the increase in IR of CT in Sweden persists and to study the treatment outcome. METHOD:Children <16 years of age diagnosed with CT during 2000-2009 and living in 1 of 5 counties in central Sweden were identified retrospectively using hospital registers. Data on clinical and biochemical characteristics and outcomes of treatment were collected from medical records. The corresponding data from 1990 to 1999 were pooled with the new data. RESULTS: In total, 113 children were diagnosed with CT during 1990-2009 in the study area. The overall IR was 2.2/100,000 person-years (95% CI 1.2-2.5/100,000 person-years). The IR was significantly higher during 2000-2009 than during 1990-1999 (2.8/100,000 [2.2-3.6] vs. 1.6/100,000 person-years [1.2-2.2], p = 0.006). The increase was significant for both sexes. Seventy percent of the patients who completed the planned initial treatment with antithyroid drugs (ATDs) and were not lost to follow-up relapsed within 3 years. Boys tended to relapse earlier than girls (6.0 months after drug withdrawal [95% CI 1.9-10.0] vs. 12.0 months [95% CI 6.8-17.3], p = 0.074). CONCLUSIONS: The IR of CT is increasing in both girls and boys. Relapse rate after withdrawal of ATD treatment is 70%. Boys tend to relapse earlier than girls, and this needs to be further investigated.
Authors: S Lohi; K Mustalahti; K Kaukinen; K Laurila; P Collin; H Rissanen; O Lohi; E Bravi; M Gasparin; A Reunanen; M Mäki Journal: Aliment Pharmacol Ther Date: 2007-11-01 Impact factor: 8.171
Authors: Mirna Abraham-Nordling; Kristina Byström; Ove Törring; Mikael Lantz; Gertrud Berg; Jan Calissendorff; Helena Filipsson Nyström; Svante Jansson; Gun Jörneskog; F Anders Karlsson; Ernst Nyström; Hans Ohrling; Thomas Orn; Bengt Hallengren; Göran Wallin Journal: Eur J Endocrinol Date: 2011-09-09 Impact factor: 6.664
Authors: Mariam Kourime; Sheena McGowan; Mabrouka Al Towati; S Faisal Ahmed; Graham Stewart; Scott Williamson; Iain Hunter; Malcolm D C Donaldson Journal: Arch Dis Child Date: 2017-12-21 Impact factor: 3.791
Authors: Laura Claire Lane; Aleksander Kuś; Tomasz Bednarczuk; Artur Bossowski; Jacek Daroszewski; Beata Jurecka-Lubieniecka; Heather Jane Cordell; Simon Henry Schofield Pearce; Timothy Cheetham; Anna Louise Mitchell Journal: J Clin Endocrinol Metab Date: 2020-09-01 Impact factor: 5.958
Authors: Christiaan F Mooij; Timothy D Cheetham; Frederik A Verburg; Anja Eckstein; Simon H Pearce; Juliane Léger; A S Paul van Trotsenburg Journal: Eur Thyroid J Date: 2022-01-01